Bacitracin

Molecular mass: 1,422.693 g/mol  PubChem compound: 10909430

Therapeutic indications

Bacitracin is indicated for:

Indication

Population group: only newborns (0 - 40 days old)

Respiratory tract infection and additionally at least one of
Empyema
Staphylococcus

For this indication, competent medicine agencies globally authorize below treatments (click for details):

Get recommendations

Factors such as age, gender, and health history are evaluated to create a personalized medication regimen.

Ask the Reasoner
< Previous: Overview
Next: Precautions >

© All content on this website, including data entry, data processing, decision support tools, "RxReasoner" logo and graphics, is the intellectual property of RxReasoner and is protected by copyright laws. Unauthorized reproduction or distribution of any part of this content without explicit written permission from RxReasoner is strictly prohibited. Any third-party content used on this site is acknowledged and utilized under fair use principles.

⇈